By utilizing existing clinical date from DisGeNET and undergoing protein-protein network analysis on cholesterol metabolism and Alzheimer’s disease, the top target genes selected were GSK3B, BACE1, SREBP2, CYP46A1, ABCA1, and TREM2. Here, ABCA1 is linked to early-onset autosomal dominant Alzheimer disease.